Status:
UNKNOWN
Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Seasonal Allergic Rhinitis
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In recent years, a number of randomized controlled trials have confirmed the efficacy and safety of acupuncture in the treatment of allergic rhinitis (AR). Indeed, the latest American clinical guideli...
Eligibility Criteria
Inclusion
- history of physician-diagnosed SAR with at least 2 years of typical symptoms, and TNSS\>=6 at v0.
- positive skin prick test (SPT) and/or positive serum antigen specific IgE to local seasonal pollens (Giant Ragweed, Mugwort, Goosefoot, etc)
Exclusion
- oral steroids within 4 weeks prior to recruitment
- nasal steroids and/or antihistamine 2 weeks prior to recruitment
- perennial AR
- any respiratory infection within the previous 4 weeks prior to recruitment
- history of nasal polyps, asthma or autoimmune disorders
- previously received acupuncture therapy for AR within 1 month prior to recruitment
Key Trial Info
Start Date :
March 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04052945
Start Date
March 25 2020
End Date
December 31 2022
Last Update
August 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hongfei Lou
Beijing, Beijing Municipality, China, 100730